Tenax Therapeutics TENX
NASDAQ TENX
$1.65 -0.04 (-2.37%)
As of: Nov 12, 2026 · 9:41 AM EST

Tenax Therapeutics (TENX) Return on Capital Employed [ROCE] (2010 - 2026)

Updated

Tenax Therapeutics (TENX) posted Return on Capital Employed [ROCE] of -60.00% for Q2 2026, down 27.08 percentage points from -32.93% a year earlier and down 1.44 percentage points from the prior quarter.

Analysis

Tenax Therapeutics (TENX) Return on Capital Employed [ROCE] (2010 - 2026) Analysis & Trends

For FY2025, Tenax Therapeutics' Return on Capital Employed [ROCE] came in at -60.43%, down 21.05 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -279.82 percentage points (FY2020 to FY2025).
  • In prior years, Tenax Therapeutics' Return on Capital Employed [ROCE] was -39.39% in FY2024 (+168.65 pp), -208.04% in FY2023 (-595.76 pp), 387.72% in FY2022 (+1060.24 pp) and -672.52% in FY2021 (-891.91 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] since Q2 2024.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last four quarters, with an average year-over-year change of +21.66 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2023, with a gain of 1942.46 percentage points; the weakest was Q1 2022, with a drop of 2584.17 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -58.56% (Q1 2026), -58.51% (Q4 2025) and -48.33% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Tenax Therapeutics 76.96 Mn -371.07 Mn - -62.65%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -62.65%
Jun 30, 2026 -60.00%
Mar 31, 2026 -58.56%
Dec 31, 2025 -58.51%
Sep 30, 2025 -48.33%
Jun 30, 2025 -32.93%
Mar 31, 2025 -26.50%
Dec 31, 2024 -20.84%
Sep 30, 2024 -48.11%
Jun 30, 2024 -172.16%
Mar 31, 2024 -123.91%
Dec 31, 2023 -137.96%
Sep 30, 2023 35.33%
Jun 30, 2023 37.36%
Mar 31, 2023 81.33%
Dec 31, 2022 496.95%
Sep 30, 2022 -917.58%
Jun 30, 2022 -1,148.98%
Mar 31, 2022 -1,861.13%
Dec 31, 2021 -555.85%
API Access

Tenax Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TENX&period=max&api_key=YOUR_API_KEY